These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 35881312)
1. Landscape of genetic variants in sporadic meningiomas captured with clinical genomics. Leclair NK; Shen E; Wu Q; Wolansky L; Becker K; Li L; Bulsara KR Acta Neurochir (Wien); 2022 Sep; 164(9):2491-2503. PubMed ID: 35881312 [TBL] [Abstract][Full Text] [Related]
2. SWI/SNF chromatin remodeling complex alterations in meningioma. Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK J Cancer Res Clin Oncol; 2021 Nov; 147(11):3431-3440. PubMed ID: 33715086 [TBL] [Abstract][Full Text] [Related]
3. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175 [TBL] [Abstract][Full Text] [Related]
4. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Clark VE; Erson-Omay EZ; Serin A; Yin J; Cotney J; Ozduman K; Avşar T; Li J; Murray PB; Henegariu O; Yilmaz S; Günel JM; Carrión-Grant G; Yilmaz B; Grady C; Tanrikulu B; Bakircioğlu M; Kaymakçalan H; Caglayan AO; Sencar L; Ceyhun E; Atik AF; Bayri Y; Bai H; Kolb LE; Hebert RM; Omay SB; Mishra-Gorur K; Choi M; Overton JD; Holland EC; Mane S; State MW; Bilgüvar K; Baehring JM; Gutin PH; Piepmeier JM; Vortmeyer A; Brennan CW; Pamir MN; Kiliç T; Lifton RP; Noonan JP; Yasuno K; Günel M Science; 2013 Mar; 339(6123):1077-80. PubMed ID: 23348505 [TBL] [Abstract][Full Text] [Related]
5. Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study. Hua L; Alkhatib M; Fujio S; Alhasan B; Herold S; Zeugner S; Zolal A; Hijazi MM; Clark VE; Wakimoto H; Shankar GM; Brastianos PK; Barker FG; Cahill DP; Ren L; Eyüpoglu IY; Gong Y; Schackert G; Juratli TA J Neurosurg; 2024 Jul; 141(1):72-78. PubMed ID: 38277657 [TBL] [Abstract][Full Text] [Related]
6. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201 [TBL] [Abstract][Full Text] [Related]
9. Life and death of molecular subclones in recurrent meningioma: A case study. Abele N; Kirches E; Sandalcioglu IE; Braunsdorf WEK; Mawrin C Clin Neuropathol; 2022; 41(4):174-178. PubMed ID: 35575414 [TBL] [Abstract][Full Text] [Related]
10. Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT. Jungwirth G; Warta R; Beynon C; Sahm F; von Deimling A; Unterberg A; Herold-Mende C; Jungk C Acta Neuropathol Commun; 2019 Aug; 7(1):140. PubMed ID: 31470906 [TBL] [Abstract][Full Text] [Related]
11. Specific gene expression signatures of low grade meningiomas. Tsitsikov EN; Hameed S; Tavakol SA; Stephens TM; Tsytsykova AV; Garman L; Bi WL; Dunn IF Front Oncol; 2023; 13():1126550. PubMed ID: 36937440 [TBL] [Abstract][Full Text] [Related]
12. Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals RB1 Signaling as a Novel Mediator and Biomarker. Parada CA; Osbun JW; Busald T; Karasozen Y; Kaur S; Shi M; Barber J; Adidharma W; Cimino PJ; Pan C; Gonzalez-Cuyar LF; Rostomily R; Born DE; Zhang J; Ferreira M Clin Cancer Res; 2020 Jan; 26(1):193-205. PubMed ID: 31615938 [TBL] [Abstract][Full Text] [Related]
13. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. Abedalthagafi MS; Merrill PH; Bi WL; Jones RT; Listewnik ML; Ramkissoon SH; Thorner AR; Dunn IF; Beroukhim R; Alexander BM; Brastianos PK; Francis JM; Folkerth RD; Ligon KL; Van Hummelen P; Ligon AH; Santagata S Oncotarget; 2014 Nov; 5(21):10596-606. PubMed ID: 25347344 [TBL] [Abstract][Full Text] [Related]
14. Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system. Yuzawa S; Nishihara H; Yamaguchi S; Mohri H; Wang L; Kimura T; Tsuda M; Tanino M; Kobayashi H; Terasaka S; Houkin K; Sato N; Tanaka S Mod Pathol; 2016 Jul; 29(7):708-16. PubMed ID: 27102344 [TBL] [Abstract][Full Text] [Related]
15. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma. Paramasivam N; Hübschmann D; Toprak UH; Ishaque N; Neidert M; Schrimpf D; Stichel D; Reuss D; Sievers P; Reinhardt A; Wefers AK; Jones DTW; Gu Z; Werner J; Uhrig S; Wirsching HG; Schick M; Bewerunge-Hudler M; Beck K; Brehmer S; Urbschat S; Seiz-Rosenhagen M; Hänggi D; Herold-Mende C; Ketter R; Eils R; Ram Z; Pfister SM; Wick W; Weller M; Grossmann R; von Deimling A; Schlesner M; Sahm F Acta Neuropathol; 2019 Aug; 138(2):295-308. PubMed ID: 31069492 [TBL] [Abstract][Full Text] [Related]
16. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689 [TBL] [Abstract][Full Text] [Related]
18. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas. Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425 [TBL] [Abstract][Full Text] [Related]
19. ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas. Chaluts D; Dullea JT; Ali M; Vasan V; Devarajan A; Rutland JW; Gill CM; Ellis E; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK J Cancer Res Clin Oncol; 2023 Jul; 149(8):5165-5172. PubMed ID: 36348021 [TBL] [Abstract][Full Text] [Related]
20. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas. Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]